More articles from Original Article

You have access
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding

Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
You have access
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian

Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
You have access
Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie

Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
You have access
Drug repurposing for cancer treatment through global propagation with a greedy algorithm in a multilayer network
Xi Cheng, Wensi Zhao, Mengdi Zhu, Bo Wang, Xuege Wang, Xiaoyun Yang, Yuqi Huang, Minjia Tan and Jing Li

Cancer Biology & Medicine January 2022, 19 (1) 74-89; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0218
You have access
Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway
Mingyan He, Jing Hu, Tingting Fang, Wenqing Tang, Bei Lv, Biwei Yang and Jinglin Xia

Cancer Biology & Medicine January 2022, 19 (1) 90-103; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0313
You have access
SNORA23 inhibits HCC tumorigenesis by impairing the 2′-O-ribose methylation level of 28S rRNA
Zhiyong Liu, Yanan Pang, Yin Jia, Qin Qin, Rui Wang, Wei Li, Jie Jing, Haidong Liu and Shanrong Liu

Cancer Biology & Medicine January 2022, 19 (1) 104-119; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0343
You have access
CUL4B facilitates HBV replication by promoting HBx stabilization
Haixia Shan, Bo Wang, Xiaodong Zhang, Hui Song, Xi Li, Yongxin Zou, Baichun Jiang, Huili Hu, Hao Dou, Changshun Shao, Lifen Gao, Chunhong Ma, Xiaoyun Yang, Xiaohong Liang and Yaoqin Gong

Cancer Biology & Medicine January 2022, 19 (1) 120-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0468
You have access
Single-cell trajectories of melanoma cell resistance to targeted treatment
Maria Schmidt, Lena Sünke Mortensen, Henry Loeffler-Wirth, Corinna Kosnopfel, Knut Krohn, Hans Binder and Manfred Kunz

Cancer Biology & Medicine January 2022, 19 (1) 56-73; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0267
You have access
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Ming Bai, Meng Wang, Ting Deng, Yuxian Bai, Kai Zang, Zhanhui Miao, Wenlin Gai, Liangzhi Xie and Yi Ba

Cancer Biology & Medicine March 2022, 19 (3) 358-369; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0388
You have access
The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma
Hua Ye, Tianqi Chen, Zhancheng Zeng, Bo He, Qianqian Yang, Qi Pan, Yueqin Chen and Wentao Wang

Cancer Biology & Medicine March 2022, 19 (3) 343-357; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0661

Main menu

User menu

Search

More articles from Original Article

Pages

Navigate

More Information

For Authors

Journal Services